Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS.

PloS one - 1 Jan 2016

Araújo-Mariz Carolline, Lopes Edmundo Pessoa, Acioli-Santos Bartolomeu, Maruza Magda, Montarroyos Ulisses Ramos, Ximenes Ricardo Arraes de Alencar, Lacerda Heloísa Ramos, Miranda-Filho Demócrito de Barros, Albuquerque Maria de Fátima P Militão de

Abstract excerpt

Hepatotoxicity is frequently reported as an adverse reaction during the treatment of tuberculosis. The aim of this study was to determine the incidence of hepatotoxicity and to identify predictive factors for developing hepatotoxicity after people living with HIV/AIDS (PLWHA) start treatment for tuberculosis. This was a prospective cohort study with PLWHA who were monitored during the first 60 days of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylation
Share to Acquired Immunodeficiency Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiretroviral Therapy, Highly Active

Share to Antitubercular Agents

Share to Arylamine N-Acetyltransferase

Share to Chemical and Drug Induced Liver Injury

Share to Life Style

Share to Tuberculosis

Source

Open in PubMed Open full text

Identifiers

PMID: 27332812
DOI: 10.1371/journal.pone.0157725
PMCID: PMC4917242

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS.PMID 27332812Read ↗

Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil.Semantic proximity Read ↗

Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and ManagementSemantic proximity Read ↗

Pharmacogenomic insights into tuberculosis treatment shows the NAT2 genetic variants linked to hepatotoxicity risk: a systematic review and meta-analysis.Semantic proximity Read ↗

The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients.Semantic proximity Read ↗

Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil.Semantic proximity Read ↗

Anti tubercular treatment induced hepatotoxicity: does acetylator status matter?Semantic proximity Read ↗

Association of N-acetyltransferase-2 genotypes and anti-tuberculosis induced liver injury; first case-controlled study from Iran.Semantic proximity Read ↗

NAT2 Polymorphisms and Antituberculosis-Induced Hepatotoxicity in Thai People Living With HIV: Insights From a Pharmacogenetic-Pharmacokinetic Cohort Study.Semantic proximity Read ↗

Influence of N-acetyltransferase 2 polymorphisms and clinical variables on liver function profile of tuberculosis patients.Semantic proximity Read ↗

Homozygotes NAT2*5B slow acetylators are highly associated with hepatotoxicity induced by anti-tuberculosis drugs.Semantic proximity Read ↗

Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs.Semantic proximity Read ↗

Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.